BioGenes GmbH, a supplier of GMP-compliant immunoassays and

The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since

The VH Group (Venkateshwara Hatcheries) is entering Europe with a state of the art poultry vaccine manufacturing facility in the Canton of Jura

November 16 – ARTES Biotechnology, specialized in recombinant protein production and process development from yeast expression systems, and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE (Cairo and Alexandria Stock Exchange: MIPH) jointly announced the successful production of a new target of a therapeutic protein.

November 13 – TET Systems Holding GmbH & Co. KG (“TET Systems”), a worldwide leader in controlled gene expression, today announced that TET Systems and Novo Nordisk A/S have signed a license agreement

October 21 – KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with Roche Diagnostics GmbH in Penzberg, Germany. Under the agreement KINAXO’s phosphoproteomics

October 15 – Graffinity Pharmaceuticals GmbH announced today that it has entered into a drug discovery research collaboration with Genentech, Inc, a wholly-owned member of the Roche Group.

October 2 – 23andMe, Inc., the industry leader in personal genetics, today announced that it is embarking on a world-wide effort to assemble the largest cohort of women whose lives have been impacted by breast cancer and to build an infrastructure, based on genetics, that will accelerate consumer-based

May 14 – 23andMe, a privately- held personal genetics company, and The Parkinson’s Institute and Clinical Center (“Parkinson’s Institute”) today announced a research initiative under which Parkinson’s Institute

January 22 -23andMe, Inc., a privately-held personal genetics company, announced today that it has begun making its services available to consumers in Canada and 49 European countries. The company,